Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...